• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性生育力保存的非肿瘤适应证。

Non-oncologic Indications for Male Fertility Preservation.

机构信息

Department of Urology, University of California San Francisco, 400 Parnassus Ave, 6th floor Suite 610, San Francisco, CA, 94143, USA.

School of Medicine, University of California San Francisco, San Francisco, CA, USA.

出版信息

Curr Urol Rep. 2019 Jul 26;20(9):51. doi: 10.1007/s11934-019-0915-3.

DOI:10.1007/s11934-019-0915-3
PMID:31346775
Abstract

PURPOSE OF REVIEW

To explore non-oncologic indications for male fertility preservation.

RECENT FINDINGS

Common scenarios in which male fertility could be irreversibly compromised include autoimmune conditions requiring treatment with cyclophosphamide, gender dysphoria prior to starting hormone therapy, military deployment, and critical illness. Fertility preservation should be considered with particular attention to the timing and logistics specific to each scenario. Recognition and familiarity with such situations will help physicians provide better counseling to patients and their families, improve the quality of decision-making, and ultimately reduce missed opportunities and regret.

摘要

目的综述

探讨男性生育力保存的非肿瘤适应证。

最近的发现

可能导致男性生育力不可逆转损害的常见情况包括需要环磷酰胺治疗的自身免疫性疾病、开始激素治疗前的性别焦虑症、军事部署和重病。应特别注意每种情况的时间安排和后勤问题,考虑生育力保存。认识和熟悉这些情况将有助于医生为患者及其家属提供更好的咨询,改善决策质量,并最终减少错失的机会和遗憾。

相似文献

1
Non-oncologic Indications for Male Fertility Preservation.男性生育力保存的非肿瘤适应证。
Curr Urol Rep. 2019 Jul 26;20(9):51. doi: 10.1007/s11934-019-0915-3.
2
Male fertility preservation-Methods, indications and challenges.男性生育力保存——方法、适应症及挑战。
Andrologia. 2021 Mar;53(2):e13635. doi: 10.1111/and.13635. Epub 2020 May 11.
3
Psychological Counseling of Female Fertility Preservation Patients.女性生育力保存患者的心理咨询
J Psychosoc Oncol. 2015;33(4):333-53. doi: 10.1080/07347332.2015.1045677.
4
Transgender men's experiences of fertility preservation: a qualitative study.跨性别男性的生育力保存经历:一项定性研究。
Hum Reprod. 2017 Feb;32(2):383-390. doi: 10.1093/humrep/dew323. Epub 2016 Dec 19.
5
Fertility Preservation Before Deployment: Oocyte and Sperm Freezing in Members of the Active Duty Military.现役军人部署前的生育力保存:卵母细胞和精子冷冻。
Semin Reprod Med. 2019 Sep;37(5-06):232-238. doi: 10.1055/s-0040-1701633. Epub 2020 Feb 10.
6
Fertility preservation in children and adolescents: current options and considerations.儿童和青少年的生育力保存:当前的选择与考量
Curr Opin Obstet Gynecol. 2017 Oct;29(5):283-288. doi: 10.1097/GCO.0000000000000395.
7
Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.巴塞罗那国际生育力保护学会-ESHRE-ASRM 2015 专家会议:生育力保存的最新进展:适应证、结果和未来展望。
Hum Reprod. 2017 Sep 1;32(9):1802-1811. doi: 10.1093/humrep/dex218.
8
Male Fertility Preservation.男性生育力保存
Curr Urol Rep. 2018 May 17;19(7):49. doi: 10.1007/s11934-018-0803-2.
9
[Immunosuppressive therapy and fertility preservation: Indications and methods].[免疫抑制治疗与生育力保存:适应证与方法]
Rev Med Interne. 2018 Jul;39(7):557-565. doi: 10.1016/j.revmed.2018.02.010. Epub 2018 Feb 28.
10
Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?睾丸癌男性的生育力保存:在辅助生殖技术时代,精子冷冻保存是否具有成本效益?
Urol Oncol. 2018 Mar;36(3):92.e1-92.e9. doi: 10.1016/j.urolonc.2017.11.002. Epub 2017 Nov 21.

引用本文的文献

1
Azilsartan as a preventive agent against cyclophosphamide-induced testicular injury in male rats.阿齐沙坦作为雄性大鼠环磷酰胺诱导的睾丸损伤的预防剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):979-990. doi: 10.1007/s00210-024-03339-6. Epub 2024 Aug 2.
2
Winter is coming: the future of cryopreservation.冬天将至:低温保存的未来。
BMC Biol. 2021 Mar 24;19(1):56. doi: 10.1186/s12915-021-00976-8.

本文引用的文献

1
Transfeminine Hormone Therapy.跨性别女性激素疗法。
Endocrinol Metab Clin North Am. 2019 Jun;48(2):341-355. doi: 10.1016/j.ecl.2019.02.001. Epub 2019 Mar 23.
2
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion.预后极差或无效的情况下的生育治疗:伦理委员会意见。
Fertil Steril. 2019 Apr;111(4):659-663. doi: 10.1016/j.fertnstert.2019.01.033. Epub 2019 Mar 11.
3
Challenges of fertility preservation in non-oncological diseases.非肿瘤性疾病中的生育力保存挑战。
Acta Obstet Gynecol Scand. 2019 May;98(5):638-646. doi: 10.1111/aogs.13577. Epub 2019 Mar 12.
4
Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.对男性系统性红斑狼疮患者进行全面的泌尿外科评估,包括精子DNA碎片化检测。
Lupus. 2019 Jan;28(1):59-65. doi: 10.1177/0961203318815764. Epub 2018 Dec 3.
5
Semen Parameters Among Transgender Women With a History of Hormonal Treatment.有激素治疗史的跨性别女性的精液参数
Urology. 2019 Feb;124:136-141. doi: 10.1016/j.urology.2018.10.005. Epub 2018 Oct 10.
6
Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review.父系全身用皮肤科药物暴露后的不孕和致畸性:系统综述。
J Am Acad Dermatol. 2019 Apr;80(4):957-969. doi: 10.1016/j.jaad.2018.09.031. Epub 2018 Oct 2.
7
Protects against Male Reproductive Damage Induced by Cyclophosphamide in Mice.可预防环磷酰胺诱导的雄性生殖损伤。
Oxid Med Cell Longev. 2018 Aug 28;2018:5758191. doi: 10.1155/2018/5758191. eCollection 2018.
8
Fertility preservation options in transgender people: A review.跨性别者的生育力保存选择:综述。
Rev Endocr Metab Disord. 2018 Sep;19(3):231-242. doi: 10.1007/s11154-018-9462-3.
9
Effects of Feminizing Hormones on Sperm Production and Malignant Changes: Microscopic Examination of Post Orchiectomy Specimens in Transwomen.女性化激素对精子生成和恶性变化的影响:对接受睾丸切除术后的跨性别女性标本进行显微镜检查
Urology. 2018 Nov;121:93-96. doi: 10.1016/j.urology.2018.07.023. Epub 2018 Aug 7.
10
Utilization of cryopreserved sperm cells based on the indication for storage.根据储存目的利用冷冻保存的精子细胞。
Investig Clin Urol. 2018 May;59(3):177-181. doi: 10.4111/icu.2018.59.3.177. Epub 2018 Apr 6.